Celltrion
068270.KS
#838
Rank
NZ$47.71 B
Marketcap
NZ$218.08
Share price
0.05%
Change (1 day)
1.86%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$1.78

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$1.84. In 2023 the company made an earnings per share (EPS) of NZ$4.77 a decrease over its 2022 EPS that were of NZ$4.87.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.78
2023NZ$4.77-2.08%
2022NZ$4.87-11.72%
2021NZ$5.512.03%
2020NZ$5.4082.8%
2019NZ$2.9618.31%
2018NZ$2.50-36.33%
2017NZ$3.92161.25%
2016NZ$1.502.86%
2015NZ$1.4617.84%
2014NZ$1.245.87%
2013NZ$1.17-70.85%
2012NZ$4.02134.09%
2011NZ$1.7243.59%
2010NZ$1.1974.49%
2009NZ$0.68317.8%
2008NZ$0.16-71.7%
2007NZ$0.58